🇺🇸 FDA
Patent

US 9248172

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

granted A61KA61K2039/6043A61K31/135

Quick answer

US patent 9248172 (Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality) held by University of Connecticut Health Center expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
University of Connecticut Health Center
Grant date
Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/6043, A61K31/135, A61K31/196, A61K31/277